<?xml version="1.0" encoding="UTF-8"?>
<p id="par0350">To give priority to high-risk and vulnerable populations, if a prophylactic or therapeutic drug, such as a monoclonal antibody becomes available, both to protect these individuals and to reduce the likelihood of an increase in serious illness and a further increase in the number of patients in hospital intensive care units.</p>
